Literature DB >> 16036063

How to grow bone to treat osteoporosis and mend fractures.

James F Whitfield1.   

Abstract

The growing number of patients with osteoporosis in our aging population need "anabolic" drugs to stimulate bone growth, improve bone microarchitecture, and accelerate fracture healing. Potent anabolic agents such as parathyroid hormone (PTH) and some of its adenylyl cyclase-stimulating fragments are either on their way, or have just now reached the clinic. This article discusses how PTHs might stimulate bone growth. The controversial bone anabolic activities of the widely used cholesterol-lowering lipophilic statins and how they might stimulate bone growth are also probed. Also, evidence is presented for leptin, a controller of body fat stores and the ovarian cycle. It has the remarkable property of being an anabolic and antianabolic that uses a hypothalamic factor to restrain osteoblast activity but by itself stimulates osteoblasts and inhibits osteoclasts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 16036063     DOI: 10.1007/s11914-003-0006-7

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  40 in total

Review 1.  The control of bone growth by parathyroid hormone, leptin, & statins.

Authors:  James F Whitfield; Paul Morley; Gordon E Willick
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2002       Impact factor: 1.807

2.  Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance.

Authors:  O Feron; C Dessy; J P Desager; J L Balligand
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

3.  Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats.

Authors:  H W Kim; J S Jahng
Journal:  Iowa Orthop J       Date:  1999

4.  Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis).

Authors:  C P Jerome; D B Burr; T Van Bibber; J M Hock; R Brommage
Journal:  Bone       Date:  2001-02       Impact factor: 4.398

5.  Rho GTPases as modulators of the estrogen receptor transcriptional response.

Authors:  L F Su; R Knoblauch; M J Garabedian
Journal:  J Biol Chem       Date:  2000-11-01       Impact factor: 5.157

6.  Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women.

Authors:  G Y Boivin; P M Chavassieux; A C Santora; J Yates; P J Meunier
Journal:  Bone       Date:  2000-11       Impact factor: 4.398

7.  Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase.

Authors:  R H Rixon; J F Whitfield; L Gagnon; R J Isaacs; S Maclean; B Chakravarthy; J P Durkin; W Neugebauer; V Ross; W Sung
Journal:  J Bone Miner Res       Date:  1994-08       Impact factor: 6.741

Review 8.  Leptin: brains and bones.

Authors:  J F Whitfield
Journal:  Expert Opin Investig Drugs       Date:  2001-09       Impact factor: 6.206

9.  Leptin reduces ovariectomy-induced bone loss in rats.

Authors:  B Burguera; L C Hofbauer; T Thomas; F Gori; G L Evans; S Khosla; B L Riggs; R T Turner
Journal:  Endocrinology       Date:  2001-08       Impact factor: 4.736

10.  Leptin receptor (OB-R) gene expression in human primary osteoblasts: confirmation.

Authors:  A Enjuanes; A Supervía; X Nogués; A Díez-Pérez
Journal:  J Bone Miner Res       Date:  2002-06       Impact factor: 6.741

View more
  1 in total

1.  Granular PEG hydrogels mediate osteoporotic MSC clustering via N-cadherin influencing the pro-resorptive bias of their secretory profile.

Authors:  Varsha V Rao; Marissa E Wechsler; Emily Cravens; Samantha J Wojda; Alexander S Caldwell; Bruce E Kirkpatrick; Seth W Donahue; Kristi S Anseth
Journal:  Acta Biomater       Date:  2022-04-20       Impact factor: 10.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.